135 related articles for article (PubMed ID: 8835322)
1. Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy.
Eto M; Horita K; Morikawa A; Nakata H; Okada M; Saito M; Nomura M; Abiko A; Iwashima Y; Ikoda A
Clin Genet; 1995 Dec; 48(6):288-92. PubMed ID: 8835322
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus.
Horita K; Eto M; Makino I
Atherosclerosis; 1994 Jun; 107(2):203-11. PubMed ID: 7980694
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.
Kimura H; Suzuki Y; Gejyo F; Karasawa R; Miyazaki R; Suzuki S; Arakawa M
Am J Kidney Dis; 1998 Apr; 31(4):666-73. PubMed ID: 9531184
[TBL] [Abstract][Full Text] [Related]
4. [Apolipoprotein E epsilon 2 allele and diabetic nephropathy].
Eto M; Saito M; Kaku K
Nihon Rinsho; 2001 Mar; 59 Suppl 3():807-11. PubMed ID: 11347178
[No Abstract] [Full Text] [Related]
5. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.
Hsieh MC; Lin SR; Yang YC; Chen HC; Lin JN; Shin SJ
J Nephrol; 2002; 15(4):368-73. PubMed ID: 12243365
[TBL] [Abstract][Full Text] [Related]
6. [The relationship of Apo E2 and renal insufficiency lipid levels in NIDDM].
Xiang G; Xia B; He Y
Zhonghua Yi Xue Za Zhi; 1999 May; 79(5):339-41. PubMed ID: 11715472
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients.
Werle E; Fiehn W; Hasslacher C
Diabetes Care; 1998 Jun; 21(6):994-8. PubMed ID: 9614620
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E allele frequencies in non-insulin-dependent diabetes mellitus with hypertriglyceridemia (type IIb, III, IV, and V hyperlipoproteinemia).
Eto M; Watanabe K; Makino I; Ishii K
Metabolism; 1991 Aug; 40(8):776-80. PubMed ID: 1861626
[TBL] [Abstract][Full Text] [Related]
9. [Insulin receptor substrate-1 and glucose transporter gene polymorphisms in noninsulin-dependent diabetes mellitus].
Liu Z; Guan T; Chen Z
Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):662-5. PubMed ID: 11038788
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients.
Eto M; Saito M; Okada M; Kume Y; Kawasaki F; Matsuda M; Yoneda M; Matsuki M; Takigami S; Kaku K
Am J Kidney Dis; 2002 Aug; 40(2):243-51. PubMed ID: 12148096
[TBL] [Abstract][Full Text] [Related]
11. Phenotypes of apolipoprotein E and abnormalities in lipid metabolism in patients with non-insulin-dependent diabetes mellitus.
Imari Y; Koga S; Ibayashi H
Metabolism; 1988 Dec; 37(12):1134-8. PubMed ID: 3193900
[TBL] [Abstract][Full Text] [Related]
12. Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy.
Liu L; Xiang K; Zheng T; Zhang R; Li M; Li J
Mol Cell Biochem; 2003 Dec; 254(1-2):353-8. PubMed ID: 14674716
[TBL] [Abstract][Full Text] [Related]
13. Apo E gene polymorphism on development of diabetic nephropathy.
Ilhan N; Kahraman N; Seçkin D; Ilhan N; Colak R
Cell Biochem Funct; 2007; 25(5):527-32. PubMed ID: 16933203
[TBL] [Abstract][Full Text] [Related]
14. Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genétique de la Nephropathie Diabétique Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Résistance Study Group.
Hadjadj S; Gallois Y; Simard G; Bouhanick B; Passa P; Grimaldi A; Drouin P; Tichet J; Marre M
Nephrol Dial Transplant; 2000 Dec; 15(12):1971-6. PubMed ID: 11096142
[TBL] [Abstract][Full Text] [Related]
15. Association between apolipoprotein E polymorphism and nephropathy in Iranian diabetic patients.
Karimoei M; Pasalar P; Mehrabzadeh M; Daneshpour M; Shojaee M; Forouzanfar K; Razi F
Saudi J Kidney Dis Transpl; 2017; 28(5):997-1002. PubMed ID: 28937055
[TBL] [Abstract][Full Text] [Related]
16. Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients.
Leiva E; Mujica V; Elematore I; Orrego R; Díaz G; Prieto M; Arredondo M
Diabetes Res Clin Pract; 2007 Nov; 78(2):196-201. PubMed ID: 17481771
[TBL] [Abstract][Full Text] [Related]
17. APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study.
Araki S; Koya D; Makiishi T; Sugimoto T; Isono M; Kikkawa R; Kashiwagi A; Haneda M
Diabetes Care; 2003 Aug; 26(8):2416-20. PubMed ID: 12882872
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E polymorphism and the progression of diabetic nephropathy in type 2 diabetes.
Tien KJ; Tu ST; Chou CW; Yang CY; Hsiao JY; Shin SJ; Chen HC; Hsieh MC
Am J Nephrol; 2011; 33(3):231-8. PubMed ID: 21346330
[TBL] [Abstract][Full Text] [Related]
19. The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy.
Erdogan M; Eroglu Z; Biray C; Karadeniz M; Cetinkalp S; Kosova B; Gunduz C; Topcuoglu N; Ozgen G; Yilmaz C
J Endocrinol Invest; 2009 Mar; 32(3):219-22. PubMed ID: 19542737
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E polymorphism and renal disease.
Oda H; Yorioka N; Ueda C; Kushihata S; Yamakido M
Kidney Int Suppl; 1999 Jul; 71():S25-7. PubMed ID: 10412731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
